The Connection Between Social Determinants of Health and Human Papillomavirus Testing Knowledge Among Women in the USA
Tóm tắt
Human papillomavirus (HPV) causes 99% of cervical cancers. In the USA, HPV testing has recently been recommended as a stand-alone option for cervical cancer screening in women over 30 years of age. Yet, studies have shown low awareness of HPV testing. This study examines awareness and knowledge that US women possess regarding HPV testing using the social determinants of health (SDOH) framework. Women aged 30 to 65 years, without hysterectomy, completed an online survey (N = 812). The outcome variables included HPV testing awareness and HPV testing knowledge, a six-item validated scale. Predictor variables included three domains of the Healthy People 2020 SDOH framework: economic stability, education, and health and healthcare. Other important sociodemographic predictors were also included. Multiple logistic and linear regression identified variables associated with HPV testing awareness and knowledge, respectively. 62.4% of the women were aware of HPV testing, and the mean knowledge score was 2.8 (out of 6). Lower awareness and knowledge were observed in older women compared with younger women and among women who had either not received HPV vaccination or were unsure of their vaccination status. Higher education attainment was associated with greater awareness and knowledge. Also, women who had a well-woman visit in the last year had better knowledge. Findings from the study can be used to develop targeted prevention strategies and initiatives to improve HPV testing awareness and knowledge to help women make more informed health decisions and promote uptake of this screening tool.
Tài liệu tham khảo
American Cancer Society (2020) Key Statistics for Cervical Cancer. Available from: https://www.cancer.org/cancer/cervical-cancer/about/key-statistics.html
Bosch FX, Lorincz A, Munoz N, Meijer CJLM, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55(4):244–265
National Cancer Institute (2019) Cancer Stat Facts: cervical cancer. Available from: https://seer.cancer.gov/statfacts/html/cervix.html
Curry SJ et al (2018) Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA 320(7):674–686
Adegoke O, Kulasingam S, Virnig B (2012) Cervical cancer trends in the United States: a 35-year population-based analysis. J Women's Health (Larchmt) 21(10):1031–1037
Isidean SD, Mayrand MH, Ramanakumar AV, Gilbert L, Reid SL, Rodrigues I, Ferenczy A, Ratnam S, Coutlée F, Franco EL, CCCaST Study Group (2016) Human papillomavirus testing versus cytology in primary cervical cancer screening: end-of-study and extended follow-up results from the Canadian cervical cancer screening trial. Int J Cancer 139(11):2456–2466
von Karsa L, Arbyn M, de Vuyst H, Dillner J, Dillner L, Franceschi S, Patnick J, Ronco G, Segnan N, Suonio E, Törnberg S, Anttila A (2015) European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination. Papillomavirus Research 1:22–31
Brown L, Ritvo P, Howlett R, Cotterchio M, Matthew A, Rosen B, Murphy J, Mai V (2007) Attitudes toward HPV testing: interview findings from a random sample of women in Ontario. Canada Health Care Women Int 28(9):782–798
Patel H, Moss EL, Sherman SM (2018) HPV primary cervical screening in England: women’s awareness and attitudes. Psychooncology 27(6):1559–1564
Kittisiam T, Tangjitgamol S, Chaowawanit W, Khunnarong J, Srijaipracharoen S, Thavaramara T, Pataradool K (2016) Knowledge and attitudes of Bangkok metropolitan women towards HPV and self-sampled HPV testing. Asian Pac J Cancer Prev 17(5):2445–2451
Chen SL et al (2014) Determinants of women’s likelihood of vaginal self-sampling for human papillomavirus to screen for cervical cancer in Taiwan: a cross-sectional study. BMC Womens Health 14:139
Giorgi Rossi P, Baldacchini F, Ronco G (2014) The possible effects on socio-economic inequalities of introducing HPV testing as primary test in cervical cancer screening programs. Front Oncol 4:20
O'Connor M, O'Leary E, Waller J, Gallagher P, Martin CM, O'Leary JJ, Sharp L, Irish Cervical Screening Research Consortium (CERVIVA) (2018) Socio-economic variations in anticipated adverse reactions to testing HPV positive: implications for the introduction of primary HPV-based cervical screening. Prev Med 115:90–96
Dodd RH, McCaffery KJ, Marlow LAV, Ostini R, Zimet GD, Waller J (2014) Knowledge of human papillomavirus (HPV) testing in the USA, the UK and Australia: an international survey. Sex Transm Infect 90(3):201–207
White A, Thompson TD, White MC, Sabatino SA, de Moor J, Doria-Rose PV, Geiger AM, Richardson LC (2017) Cancer screening test use - United States, 2015. MMWR Morb Mortal Wkly Rep 66(8):201–206
U.S. Department of Health and Human Services (2014) Social determinants of health. Available from: https://www.healthypeople.gov/2020/topics-objectives/topic/social-determinants-of-health
US Cancer Statistics Working Group 2018 U.S. cancer statistics data visualization tool. [cited 2018 October]; Available from: https://gis.cdc.gov/Cancer/USCS/DataViz.html
Waller J, Ostini R, Marlow LAV, McCaffery K, Zimet G (2013) Validation of a measure of knowledge about human papillomavirus (HPV) using item response theory and classical test theory. Prev Med 56(1):35–40
Thompson EL, Rosen BL, Maness SB (2019) Social determinants of health and human papillomavirus vaccination among young adults, national health interview survey 2016. J Community Health 44(1):149–158
Tatar O, Thompson E, Naz A, Perez S, Shapiro GK, Wade K, Zimet G, Gilca V, Janda M, Kahn J, Daley E, Rosberger Z (2018) Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: a mixed methods research synthesis. Prev Med 116:40–50
Blake KD, Ottenbacher AJ, Finney Rutten LJ, Grady MA, Kobrin SC, Jacobson RM, Hesse BW (2015) Predictors of human papillomavirus awareness and knowledge in 2013: gaps and opportunities for targeted communication strategies. Am J Prev Med 48(4):402–410
McBride KR, Singh S (2018) Predictors of adults’ knowledge and awareness of HPV, HPV-associated cancers, and the HPV vaccine: implications for health education. Health Educ Behav 45(1):68–76
Markowitz LE et al (2014) Human papillomavirus vaccination: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 63(5):1–30
Saei Ghare Naz M et al (2018) Educational Interventions for cervical cancer screening behavior of women: a systematic review. Asian Pac J Cancer Prev 19(4):875–884